Agenda

 MS Symposium Header 

 

Thursday, October 4, 2012   

6:30 p.m.

Evening Welcome Reception/Registration/Tour of the Mandell MS Center   

The Joyce D. and Andrew J. Mandell Center for Comprehensive Multiple Sclerosis Care & Neuroscience Research at Mount Sinai Rehabilitation Hospital a Saint Francis Care Provider 

Friday, October 5, 2012   

7:30 a.m.

Connecticut Convention Center
 Registration/Continental Breakfast/Exhibits  

8:00–9:00 a.m.

Welcome Plenary Panel  

Evolution and Revolution in MS: Comprehensive Care and Research 

Albert Lo, M.D., Ph.D.
Nicholas G. LaRocca, Ph.D

Timothy Vollmer, M.D., F.A.A.N.

June Halper, M.S.N., A.P.N.-C., M.S.C.N., F.A.A.N.

9:00–10:30 a.m.

Concurrent Morning Sessions  

Session I:  MS Epidemiology: Update On Longitudinal Studies in North America 

Stephen Buka, Sc.D. 

 Mitchell T. Wallin, M.D., M.P.H. 

Helen Tremlett, Ph.D. 

 

Session II:  MS Genetics, Imaging, Stem Cell Regeneration 

Daniel Pelletier, M.D. 

Stephen J. Crocker, Ph.D. 

Philip L. De Jager, M.D., Ph.D. 

 

10:30–10:45 a.m.

Refreshment Break & Exhibits   

10:45 a.m.–12:15 p.m.

Rehabilitation Research: Session I 

Susan E. Bennett, P.T., D.P.T., Ed.D., N.S., M.S.C.S.,

Peter Feys, M.Sc., Ph.D.,

Nancy Chiaravalloti, Ph.D.

 

12:30 – 1:30 p.m.

Lunch 

1:45 – 3:15 p.m.

Rehabilitation Research: Session II 

Pamela W. Duncan, Ph.D., P.T., F.A.P.T.A., F.A.H.A.  

Francois Bethoux, M.D.  

Claude Vaney, M.D. 

3:15 – 4:15 p.m.

Refreshment Break & Exhibits 
 

4:30 – 5:30 p.m.

International Perspectives on MS Health Economics and Comprehensive Care:  Canadian & U.S. Perspectives 

T. Jock Murray, M.D. 

Christopher T. Bever, Jr., M.D., M.B.A. 

Craig I. Coleman, Pharm.D. 

6:30 – 9:00 p.m.

Dinner & Discussion  

Saturday, October 6, 2012   

7:30-8:30 a.m. Registration and Continental breakfast  

8:30 – 9:45 a.m.

Healthy Diet Choices and Molecular Research Considerations 

Allen Bowling, M.D., Ph.D. 

Paolo Riccio 

Mollie Katzen 

Albert Lo, M.D., Ph.D. 

10:00-11:00 a.m.

Therapies on the Horizon and Enhancing DMT Use 

Timothy Vollmer, M.D., F.A.A.N. 

Peter Wade, M.D. 

 

11:15 a.m.– 12:30 p.m.

Concurrent Morning Sessions  

Session I: Symptom Management 

Robert J. Krug, M.D. 

Marlene A. Murphy-Setzko, M.D. 

Ben Thrower, M.D. 

 

Session II: Personal Financial Management for People with MS and their Families 

Martin Shenkman C.PA., M.B.A., P.F.S., A.E.P., J.D. 

12:30 – 1:30 p.m.

Closing Keynote Address & Lunch 

Role of Philanthropy and Advocacy for MS  

Exhibits   

“The ultimate goal of research in multiple sclerosis (MS) is the development of interventions that can improve the lives of those living with MS and prevent or cure MS. However, understanding of the MS disease process is not yet sufficient to predict which therapeutic strategies will be most effective. While the new disease-modifying drugs are a major leap forward, they are not a cure, nor are they effective for all patients. MS remains a mysterious disease with no known pathogen.”(Institute of Medicine Report on MS, 2001)  

This conference is sponsored by the Joyce D. and AndreMS logow J. Mandell Center for Comprehensive Multiple Sclerosis Care & Neuroscience Research at Mount Sinai Hospital, a Saint Francis Care provider, in collaboration with the National Multiple Sclerosis Society.